A share price of Pfizer Inc [PFE] is currently trading at $23.04, down -2.04%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PFE shares have gain 4.63% over the last week, with a monthly amount glided 2.26%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pfizer Inc [NYSE: PFE] stock has seen the most recent analyst activity on April 22, 2025, when Cantor Fitzgerald initiated its Neutral rating and assigned the stock a price target of $24. On November 15, 2024, Wolfe Research initiated with a Underperform rating and assigned a price target of $25 on the stock. Bernstein initiated its recommendation with a Mkt Perform and recommended $32 as its price target on October 17, 2024. Daiwa Securities upgraded its rating to Outperform for this stock on August 07, 2024. In a note dated March 22, 2024, Argus downgraded an Hold rating on this stock.
Pfizer Inc experienced fluctuations in its stock price throughout the past year between $20.92 and $31.54. Currently, Wall Street analysts expect the stock to reach $28 within the next 12 months. Pfizer Inc [NYSE: PFE] shares were valued at $23.04 at the most recent close of the market. An investor can expect a potential return of 21.53% based on the average PFE price forecast.
Analyzing the PFE fundamentals
Trailing Twelve Months sales for Pfizer Inc [NYSE:PFE] were 62.46B which represents -7.82% decline. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.13%.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Pfizer Inc [NYSE:PFE] is 1.26. In addition, the Quick Ratio stands at 0.96. Considering the valuation of this stock, the price to sales ratio is 2.10, the price to book ratio is 1.45 and price to earnings (TTM) ratio is 16.70.
Transactions by insiders
Recent insider trading involved Dolsten Mikael, Former Officer, that happened on May 05 ’25 when 55000.0 shares were purchased. SVP & Controller, DAMICO JENNIFER B. completed a deal on Mar 04 ’25 to sell 2500.0 shares. Meanwhile, Director BLAYLOCK RONALD E bought 19457.0 shares on Feb 13 ’25.
